An unequal activism for an unequal epidemic?
This paper observes that a substantially large moral duty of dealing with the AIDS situation in Africa has been placed on the drug companies and argues that this approach is inequitable. Using the poverty-AIDS relationship and the human rights framework it argues for a more balanced AIDS activism, which puts equal pressure on all potential stakeholders in the war against AIDS. It argues that this redistribution of the HIV/AIDS moral burden is perhaps the only hope for curbing the African AIDS epidemic that continues to ravage communities on that continent.
Selemogo
Mpho
M
4/37 Saunders Street, Coburg, Victoria, 3058, Australia. mphogift@yahoo.com.
D000349:Africa; D019380:Anti-HIV Agents / Q000191:economics*; D003695:Delivery of Health Care / Q000592:standards; D003906:Developing Countries; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000941:ethics*; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control*; D006297:Health Services Accessibility / Q000191:economics / Q000941:ethics; D006304:Health Status; D006806:Human Rights; D006801:Humans; D007391:International Cooperation; D011203:Poverty; D017149:Private Sector; D011634:Public Health; D017150:Public Sector; D012941:Social Responsibility; D012959:Socioeconomic Factors
D019380:Anti-HIV Agents